# Jean-Paul Sanday

> Jean-Paul Sanday is a Series B investor at Menlo Ventures backing Artificial Intelligence. See 18 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Menlo Ventures](https://shizune.co/investors/profile/menlo-ventures)
- Location: Menlo Park, United States
- Total investments: 18
- Last investment: Jun 2026
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jpsanday/
- X (Twitter): https://twitter.com/jpsanday
- Website: https://x.com/jpsanday
- Facebook: https://www.facebook.com/jpsanday/

Jean-Paul Sanday is a Series B investor at Menlo Ventures in Menlo Park focused on Artificial Intelligence and Software. Jean-Paul Sanday is based out of Menlo Park, California and is the Partner of Menlo Ventures. Jean previously worked at Summit Partners as a Vice President. Jean-Paul Sanday attended the University of Stanford Graduate School of Business.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Artificial Intelligence | 6 | 33% |
| Software | 4 | 22% |
| Health Care | 4 | 22% |
| SaaS | 3 | 17% |
| Medical | 3 | 17% |

46 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 9 | 50% |
| Series C | 6 | 33% |
| Series A | 2 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 12 | 67% |
| Sweden | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Assort Health | Assort Health is building healthcare that remembers.From call center automation and form intake to referrals, document processing, outreach, and payments, we manage the entire patient journey for providers. Our platform is the most widely used AI agents platform for the patient journey, built on 180 million specialty patient interactions and amodel that handles the complexity general-purpose AI can’t.Healthcare organizations see a 5% lift in appointment volume, a 115% increase in labor capacity, and a 4.3 out of 5 patient satisfaction score.With over $222M raised from Menlo Ventures, Lightspeed, First Round Capital, Apolo Ohno, and Joe Montana, Assort is becoming the standard for how providers use AI to transform the patient journey.Learn more at assorthealth.com | $120M | Series C | Jun 24, 2026 |  |
| Nourish | Nourish is a healthcare technology company that connects patients with registered dietitians through virtual nutrition counseling services covered by insurance plans. The platform allows users to find dietitians based on their health goals and attend appointments through telehealth, while also offering tools for meal tracking, goal monitoring, andnutrition guidance through its mobile application. Nourish works with registered dietitian nutritionists who provide support for conditions such as diabetes, weight management, cardiovascular health, eating disorders, and pediatric nutrition care. The company states that it partners with major insurance providers to reduce out-of-pocket costs for patients and offers ongoing nutritional care through recurring consultations. In addition to patient services, Nourish publishes educational resources and uses data-driven approaches to support personalized nutrition planning and long-term health management. | $100M | Series C | May 19, 2026 |  |
| Solace | Solace is a digital health platform that connects patients with expert healthcare advocates. Their health advocates are former doctors, nurses, pharmacists, and other clinical and experience-driven professionals who navigate patients through healthcare challenges. | $130M | Series C | Feb 10, 2026 |  |
| Solace | Solace is a digital health platform that connects patients with expert healthcare advocates. Their health advocates are former doctors, nurses, pharmacists, and other clinical and experience-driven professionals who navigate patients through healthcare challenges. | $60M | Series B | Apr 03, 2025 |  |
| CollegeVine | CollegeVine is a platform for deploying AI Agents to replace administrative work throughout the higher education sector and to save time and money for Universities (Colleges) globally. The higher education sector is projecting an annual deficit of $100B within 5 years. We believe AI Agents will dramatically increase efficiency, reduceadministrative costs, and transform the student experience to make higher education sustainable for the next century. We deploy safe AI Agents to drive real outcomes across campus.Over 100 universities use CollegeVine AI Agents to dramatically change how their administrative staff does work. |  | Series C | Jan 01, 2025 |  |
| OfferFit | OfferFit is an AI-powered experimentation platform that automates decision-making and personalization for businesses. It enables companies to optimize customer engagement strategies by continuously testing and learning from various offers and interactions. The platform leverages machine learning to deliver tailored recommendations, improvingmarketing effectiveness and customer experience. | $25M | Series B | Nov 14, 2023 |  |
| Sana | Sana Labs is the global leader in the development and application of artificial intelligence to learning. We partner with the world’s leading organizations to transform learning outcomes with personalized learning.The interdisciplinary teams consist of experienced engineers and scientists with backgrounds ranging from Google AI and Spotify toImperial College and BCG Gamma. | $34M | Series B | Dec 05, 2022 |  |
| Knoetic | Knoetic is an online platform built for chief people officers and unify a social network and a SaaS analytics tool in the same platform. Knoetic, a startup "built with Chief People Officers, for Chief People Officers," announced an $18M Series A round of funding led by Accel. Over 100 angel investors also participated in the round,including New York Times bestselling author Adam Grant, and executives from Box, Figma, Johnson & Johnson, LinkedIn, Scale, Pinterest, Calm, Front, and more. Knoetic is the first company to unify a social network and a SaaS analytics tool in the same platform. By embedding its exclusive social network of 1,000+ world-class Chief People Officers, CPOHQ, directly into its people analytics software, the resulting "Insight Engine" gives CPOs both quantitative and qualitative insights, enabling them to make smarter, holistic decisions about their workforce. Chief People Officers use Knoetic to build their board decks, present data to their CEOs, solve challenges with peers, and improve their employee retention, compensation, and hiring. The rapidly-growing startup's customer + community base includes many of the world's top technology companies, including Lyft, Squarespace, Amplitude, Snyk, Dollar Shave Club, and Zapier. Over 1,000 other Chief People Officers use Knoetic's exclusive, referral-only community (named CPOHQ) to discuss their most pressing challenges. These include navigating the COVID delta variant, transitioning to remote work, and scaling through hypergrowth. | $36M | Series B | Sep 21, 2022 |  |
| Koala Health | Koala has all the medications and health products your pet needs. We package them by date and time to make pet care simpler. The best part? There are no service or shipping fees — you only pay for what your pet needs. | $20M | Series A | Sep 07, 2022 |  |
| H1.co | H1 is an AI-powered platform that helps identify and engage the right doctors for critical workflows across pharma, health plan, health system, and technology companies. At the core of the platform is H1’s Doctor Graph—a structured representation of physician identity, expertise, relationships, and behavioral signals, creating a powerful networkeffect as it is continuously enriched by participants across the healthcare ecosystem. Built on one of the world’s largest and most comprehensive global datasets of healthcare professionals, H1 combines deep healthcare data with agentic AI workflows to power critical workflows across drug development, medical and commercial engagement, care navigation, and provider data and network intelligence. Founded in 2017, the company is based in New York, United States. | $23M | Series C | Jun 09, 2022 |  |

10 of 18 investments shown.

## Co-investors
- [IVP](https://shizune.co/investors/profile/institutional-venture-partners) — VC Fund, 10 deals together
- [Inspired Capital Partners](https://shizune.co/investors/profile/inspired-capital-partners) — VC Fund, 4 deals together
- [dRx Capital](https://shizune.co/investors/profile/drx-capital) — VC Fund, 3 deals together
- [Greylock](https://shizune.co/investors/profile/greylock) — VC Fund, 3 deals together
- [Headline](https://shizune.co/investors/profile/headlinevc) — VC Fund, 3 deals together
- [Lightspeed Venture Partners](https://shizune.co/investors/profile/lightspeed-venture-partners) — VC Fund, 3 deals together

## About Menlo Ventures

VC Fund · San Francisco, United States

Menlo Ventures provides capital for multi-stage consumer, enterprise, and life sciences technology companies. Since 1976, the firm’s market-driven analysis has led to the identification of opportunities and successful investments in innovative markets. Notable areas of investment include Marketplaces (Uber, Rover.com, Poshmark); Consumer Services(Tumblr, Betterment, Roku, Siri); Dev/Ops (Harness, Edge Delta, Fire hydrant); SaaS (Carta, ScoutRFP, Qualia, Benchling, Everlaw); Fintech (Betterment, Bluevine, Chime); Cybersecurity (Cavium, IronPort, BitSight, Abnormal, StackRox); and Life Sciences Technology (Synthego, Cofactor Genomics, Recursion Pharmaceuticals, 3T Biosciences). Menlo’s portfolio includes more than 70 public companies, and more than 100 mergers and acquisitions, with $5 billion under management. The firm is currently investing in Menlo Ventures XV, a $500 million early-stage fund, as well as its $500 million Inflection Fund, which targets early-growth investments.

5 contacts available at Menlo Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Henry Montgomery | Founder and Partner Emeritus | https://shizune.co/investors/profile/dubose-montgomery |
| Jean-Paul Sanday | Partner | https://shizune.co/investors/profile/jean-paul-sanday |
| John Jarve | Partner Emeritus | https://shizune.co/investors/profile/john-jarve |
| Johnny Hu | Principal | https://shizune.co/investors/profile/johnny-hu |
| Steve Sloane | Partner | https://shizune.co/investors/profile/steve-sloane |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Jean-Paul Sanday invest in?

Jean-Paul Sanday invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Series B and Series C stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jean-Paul Sanday last invest?

The most recent investment recorded for Jean-Paul Sanday closed in Jun 2026. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co